GlassScriptPhysician profile
Katelyn Molnar
NPI 1730942202
$610.93
in general payments reported to CMS, 2019-2025
11 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $367 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.94 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $150.36 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $119.59 | 2024-2025 | Myfembree |
| Davol INC. | $72.99 | 2025 | Arista |
| Medtronic, INC. | $70.09 | 2024 | Interstim |
| Exeltis, USA INC. | $52.67 | 2025 | Slynd |
| Organon LLC | $36.42 | 2024 | |
| Pfizer INC. | $31.94 | 2024 | |
| Hologic Sales and Service, LLC | $25.83 | 2024 | Aptima |
| Smith+Nephew, INC. | $23.99 | 2024 | Pico 7 |
| Sage Therapeutics, LLC | $15.14 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $11.91 | 2025 | Solosec, Phexx, Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Molnar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.